23-C-Substituted mycaminosyl tylonolide, pharmaceutical composit

Details 23-C-Substituted mycaminosyl tylonolide, pharmaceutical composit 23-C-Substituted mycaminosyl tylonolide, pharmaceutical composit

1985-04-03

1986-03-18

Brown, Johnnie R.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

536 71, A61K 3178, C07H 1708

Patent

active

045769311

ABSTRACT:
Novel 23-C-substituted mycaminosyl tylonolide of the general formula (I) ##STR1## wherein R.sup.1 represents a lower alkyl group, an aryl group, a lower alkenyl group or a lower alkynyl group, R.sup.2 represents a hydrogen atom or a hydroxyl group.
These compounds have excellent antibacterial activities.

REFERENCES:
patent: 4056616 (1977-11-01), Reimann et al.
patent: 4401660 (1983-08-01), Kirst
Pigman et al., "Chemistry of the Carbohydrates", 1948, Academic Press Inc., New York, N.Y.

Affiliated with

Also associated with

Rating

23-C-Substituted mycaminosyl tylonolide, pharmaceutical composit does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 23-C-Substituted mycaminosyl tylonolide, pharmaceutical composit, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 23-C-Substituted mycaminosyl tylonolide, pharmaceutical composit will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2306188